|
|
|
|
Nearly Half Of Rheumatoid Arthritis Sufferers Feel Early Treatment Would Have Given Them More Independence
A UK survey of 575 rheumatoid arthritis sufferers highlights the importance of maintaining independence and the significant impact that early diagnosis and treatment can have.Over 94% of those surveyed claimed that their...
|
|
|
Risk of TB Higher for Patients Taking Infliximab, Adalimumab, Than Etanercept
my personal edition> rheumatoid arthritis > news E-Mail this DGNews to a colleague DGNews HOBOKEN, NJ -- July 2, 2009 -- A study published in the July issue of Arthritis & Rheumatism examined cases of...
|
|
|
Patients who have been diagnosed with arthritis in Newfoundland and Labrador are waiting four years to see a s
Sean Hamilton says arthritis patients in Newfoundland and Labrador are woefully underserved.(CBC) 'The problem is there aren't enough rheumatologists to serve the province. That's the bottom line,' Dr. Sean Hamilton, the chief...
|
|
|
Study provides greater understanding of lyme disease-causing bacteria
Lyme disease in the U.S.is caused by the tick-borne bacteria Borrelia burgdorferi and usually begins with a skin lesion, after which the bacteria spread throughout the body to the nervous system, heart or joints. About 60 percent of...
|
|
|
Gene expression findings may lead to better classification & treatment of juvenile arthritis: Study
Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA).Eventually such findings could enable doctors to target more...
|
|
|
Study Provides Greater Understanding Of Lyme Disease-Causing Bacteria
Lyme disease in the U.S.is caused by the tick-borne bacteria Borrelia burgdorferi and usually begins with a skin lesion, after which the bacteria spread throughout the body to the nervous system, heart or joints. About 60 percent of...
|
|
|
Certain arthritis drugs affect TB risk
The risk of tuberculosis for patients who take arthritis drugs differs from that of the French population at large depending on the agent used, researchers say.Treatment with anti-tumor necrosis factor agents is recognized as a risk...
|
|
|
Examining The Risk Of Tuberculosis From Arthritis Medication
Treatment with anti-tumor necrosis factor (TNF) agents is recognized as a risk factor for tuberculosis (TB) in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease,...
|
|
|
Risk of tuberculosis from arthritis medication examined
Treatment with anti-tumor necrosis factor (TNF) agents is recognized as a risk factor for tuberculosis (TB) in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease,...
|
|
|
Medical News: MorphoSys And The University Of Melbourne File New Patent Applications In MOR103 Program
Arthritis / Rheumatology News Main Category: Arthritis / Rheumatology email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health Professional: Article Opinions:...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
Savient Pharmaceuticals, Inc.(NASDAQ:SVNT) announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of 14 to 1 that KRYSTEXXA(TM) (pegloticase), a biologic...
|
|
|
New Drug Promising Against Rheumatoid Arthritis
Golimumab might help where similar drugs failed, research finds -- Robert Preidt MONDAY, June 29 (HealthDay News) -- The immunosuppressive drug golimumab shows promise in treating rheumatoid arthritis patients who don't respond to...
|
|
|
June 2009 Briefing - Rheumatology
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for June 2009.This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes...
|
|
|
Medarex to Receive Milestone Payment for the Approval of Ilaris for the Treatment of Cryopyrin-Associated Peri
Other Inflammatory Disease Studies Underway in Systemic Juvenile Idiopathic Arthritis, Some Forms of Gout and Type 2 Diabetes PRINCETON, N.J.--(BUSINESS WIRE)--Jun 30, 2009 - Medarex, Inc.(NASDAQ:MEDX) today announced it will...
|
|
|
Gene Expression Findings a Step Toward Better Classification and Treatment of Juvenile Arthritis
Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA).Eventually such findings could enable doctors to target more...
|
|
|
Better Classification And Treatment Of Juvenile Arthritis Via Gene Expression
Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA).Eventually such findings could enable doctors to target more...
|
|
|
Rheumatoid Arthritis: New Treatment Target?
Scientists Find Compound, Called Tenascin-C, Which May Contribute to Rheumatoid Arthritis June 30, 2009 -- Scientists have found a potential new target for rheumatoid arthritis treatment.That target is an immune system...
|
|
|
Rheumatoid Arthritis: New Treatment Target?
Scientists Find Compound, Called Tenascin-C, Which May Contribute to Rheumatoid Arthritis By Miranda Hitti WebMD Health News Reviewed By June 30, 2009 -- Scientists have found a potential new target for rheumatoid arthritis...
|
|
|
Greater Understanding Of Lyme Disease-causing Bacteria
Lyme disease in theU.S.is caused by the tick-borne bacteria Borrelia burgdorferi and usually begins with a skin lesion, after which the bacteria spread throughout the body to the nervous system, heart or joints. About 60 percent of...
|
|
|
New Drug Promising Against Rheumatoid Arthritis
MONDAY, June 29 (HealthDay News) -- The immunosuppressive drug golimumab shows promise in treating rheumatoid arthritis patients who don't respond to other drugs, according to a new study.Golimumab is from the family of drugs called...
|
|
|
Arthritis Is Making a Killing in a Maturing Market
By Michael Harris BioWorld Executive Editor I well remember the day I ceded control of my spinal column.Years ago, I bent over at the waist with my daughter in one arm to pick up my house keys. I felt a disturbance in my lumbar force...
|
|
|
Infants should be screened for hip trouble
Rosemont, Ill -- Developmental hip dysplasia is the most common congenital defect in newborns.The condition occurs when a hip joint is shallow, unstable or when the joint is dislocated. Infants with the condition are often at risk of...
|
|
|
Jury awards Centocor $1.7B in patent case against Abbott
Philadelphia Business Journal Related News Centocor Ortho Biotech Inc.said late Monday that a federal jury in Texas has awarded the company $1.67 billion in a patent infringement case against Abbott Laboratories. An Abbott spokesman...
|
|
|
Centocor wins $1.67 billion court decision
A federal court in Texas has ordered Abbott Laboratories to pay Centocor Ortho Biotech Inc.$1.67 billion in damages for patent infringement. Abbott has pledged to appeal the verdict. In the verdict handed down late Monday, an Eastern...
|
|
|
Pozen files drug application for its 'purple pill' Nexium combo to combat arthritis
Chapel Hill, N.C.Pozen (Nasdaq: POZN) and its partner AstraZeneca have filed a new drug application with the U.S. Food and Drug Administration for their proposed treatment targeting arthritis. Newly named Vimovo, the drug...
|
